Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
Market Analysis and Insights: Global Cancer Hormone Therapy Drugs Market
The global Cancer Hormone Therapy Drugs market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Cancer Hormone Therapy Drugs Scope and Segment
The global Cancer Hormone Therapy Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Hormone Therapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other
By the application, this report covers the following segments
Breast Cancer
Prostate Cancer
Competitive Landscape:
The Cancer Hormone Therapy Drugs key manufacturers in this market include:
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen
Market Analysis and Insights: Global Cancer Hormone Therapy Drugs Market
The global Cancer Hormone Therapy Drugs market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Cancer Hormone Therapy Drugs Scope and Segment
The global Cancer Hormone Therapy Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Hormone Therapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other
By the application, this report covers the following segments
Breast Cancer
Prostate Cancer
Competitive Landscape:
The Cancer Hormone Therapy Drugs key manufacturers in this market include:
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen
1 Market Overview of Cancer Hormone Therapy Drugs
1.1 Cancer Hormone Therapy Drugs Market Overview
1.1.1 Cancer Hormone Therapy Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Hormone Therapy Drugs Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Cancer Hormone Therapy Drugs Market Size by Region (2015-2026)
1.4 Global Cancer Hormone Therapy Drugs Historic Market Size by Region (2015-2020)
1.5 Global Cancer Hormone Therapy Drugs Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.1 North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.2 Europe Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.3 China Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.5 Latin America Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
2 Cancer Hormone Therapy Drugs Market Overview by Type
2.1 Global Cancer Hormone Therapy Drugs Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2015-2020)
2.3 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2021-2026)
2.4 Tamoxifen
2.5 Aromatase Inhibitors
2.6 Antiandrogens
2.7 Androgen Synthesis Inhibitors
2.8 Other
3 Cancer Hormone Therapy Drugs Market Overview by Application
3.1 Global Cancer Hormone Therapy Drugs Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Cancer Hormone Therapy Drugs Historic Market Size by Application (2015-2020)
3.3 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2021-2026)
3.4 Breast Cancer
3.5 Prostate Cancer
4 Global Cancer Hormone Therapy Drugs Competition Analysis by Players
4.1 Global Cancer Hormone Therapy Drugs Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Hormone Therapy Drugs as of 2019)
4.3 Date of Key Manufacturers Enter into Cancer Hormone Therapy Drugs Market
4.4 Global Top Players Cancer Hormone Therapy Drugs Headquarters and Area Served
4.5 Key Players Cancer Hormone Therapy Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Hormone Therapy Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business and Company’s Total Revenue
5.1.3 Roche Products, Services and Solutions
5.1.4 Roche Revenue (US$ Million) (2015-2020)
5.1.5 Roche Recent Development and Reaction to Covid-19
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business and Company’s Total Revenue
5.2.3 Amgen Products, Services and Solutions
5.2.4 Amgen Revenue (US$ Million) (2015-2020)
5.2.5 Amgen Recent Development and Reaction to Covid-19
5.3 Pfizer
5.5.1 Pfizer Profile
5.3.2 Pfizer Main Business and Company’s Total Revenue
5.3.3 Pfizer Products, Services and Solutions
5.3.4 Pfizer Revenue (US$ Million) (2015-2020)
5.3.5 Teva Recent Development and Reaction to Covid-19
5.4 Teva
5.4.1 Teva Profile
5.4.2 Teva Main Business and Company’s Total Revenue
5.4.3 Teva Products, Services and Solutions
5.4.4 Teva Revenue (US$ Million) (2015-2020)
5.4.5 Teva Recent Development and Reaction to Covid-19
5.5 Takeda
5.5.1 Takeda Profile
5.5.2 Takeda Main Business and Company’s Total Revenue
5.5.3 Takeda Products, Services and Solutions
5.5.4 Takeda Revenue (US$ Million) (2015-2020)
5.5.5 Takeda Recent Development and Reaction to Covid-19
5.6 Samyang Biopharmaceuticals
5.6.1 Samyang Biopharmaceuticals Profile
5.6.2 Samyang Biopharmaceuticals Main Business and Company’s Total Revenue
5.6.3 Samyang Biopharmaceuticals Products, Services and Solutions
5.6.4 Samyang Biopharmaceuticals Revenue (US$ Million) (2015-2020)
5.6.5 Samyang Biopharmaceuticals Recent Development and Reaction to Covid-19
5.7 Tolmar
5.7.1 Tolmar Profile
5.7.2 Tolmar Main Business and Company’s Total Revenue
5.7.3 Tolmar Products, Services and Solutions
5.7.4 Tolmar Revenue (US$ Million) (2015-2020)
5.7.5 Tolmar Recent Development and Reaction to Covid-19
5.8 AstraZeneca
5.8.1 AstraZeneca Profile
5.8.2 AstraZeneca Main Business and Company’s Total Revenue
5.8.3 AstraZeneca Products, Services and Solutions
5.8.4 AstraZeneca Revenue (US$ Million) (2015-2020)
5.8.5 AstraZeneca Recent Development and Reaction to Covid-19
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business and Company’s Total Revenue
5.9.3 Novartis Products, Services and Solutions
5.9.4 Novartis Revenue (US$ Million) (2015-2020)
5.9.5 Novartis Recent Development and Reaction to Covid-19
5.10 Aspen
5.10.1 Aspen Profile
5.10.2 Aspen Main Business and Company’s Total Revenue
5.10.3 Aspen Products, Services and Solutions
5.10.4 Aspen Revenue (US$ Million) (2015-2020)
5.10.5 Aspen Recent Development and Reaction to Covid-19
6 North America Cancer Hormone Therapy Drugs by Players and by Application
6.1 North America Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
6.2 North America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
7 Europe Cancer Hormone Therapy Drugs by Players and by Application
7.1 Europe Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
7.2 Europe Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
8 China Cancer Hormone Therapy Drugs by Players and by Application
8.1 China Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
8.2 China Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
9 Rest of Asia Pacific Cancer Hormone Therapy Drugs by Players and by Application
9.1 Rest of Asia Pacific Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
10 Latin America Cancer Hormone Therapy Drugs by Players and by Application
10.1 Latin America Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
10.2 Latin America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
11 Middle East & Africa Cancer Hormone Therapy Drugs by Players and by Application
11.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
12 Cancer Hormone Therapy Drugs Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
1.1 Cancer Hormone Therapy Drugs Market Overview
1.1.1 Cancer Hormone Therapy Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Hormone Therapy Drugs Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Cancer Hormone Therapy Drugs Market Size by Region (2015-2026)
1.4 Global Cancer Hormone Therapy Drugs Historic Market Size by Region (2015-2020)
1.5 Global Cancer Hormone Therapy Drugs Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.1 North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.2 Europe Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.3 China Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.5 Latin America Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2026)
2 Cancer Hormone Therapy Drugs Market Overview by Type
2.1 Global Cancer Hormone Therapy Drugs Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2015-2020)
2.3 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2021-2026)
2.4 Tamoxifen
2.5 Aromatase Inhibitors
2.6 Antiandrogens
2.7 Androgen Synthesis Inhibitors
2.8 Other
3 Cancer Hormone Therapy Drugs Market Overview by Application
3.1 Global Cancer Hormone Therapy Drugs Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Cancer Hormone Therapy Drugs Historic Market Size by Application (2015-2020)
3.3 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2021-2026)
3.4 Breast Cancer
3.5 Prostate Cancer
4 Global Cancer Hormone Therapy Drugs Competition Analysis by Players
4.1 Global Cancer Hormone Therapy Drugs Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Hormone Therapy Drugs as of 2019)
4.3 Date of Key Manufacturers Enter into Cancer Hormone Therapy Drugs Market
4.4 Global Top Players Cancer Hormone Therapy Drugs Headquarters and Area Served
4.5 Key Players Cancer Hormone Therapy Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Hormone Therapy Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business and Company’s Total Revenue
5.1.3 Roche Products, Services and Solutions
5.1.4 Roche Revenue (US$ Million) (2015-2020)
5.1.5 Roche Recent Development and Reaction to Covid-19
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business and Company’s Total Revenue
5.2.3 Amgen Products, Services and Solutions
5.2.4 Amgen Revenue (US$ Million) (2015-2020)
5.2.5 Amgen Recent Development and Reaction to Covid-19
5.3 Pfizer
5.5.1 Pfizer Profile
5.3.2 Pfizer Main Business and Company’s Total Revenue
5.3.3 Pfizer Products, Services and Solutions
5.3.4 Pfizer Revenue (US$ Million) (2015-2020)
5.3.5 Teva Recent Development and Reaction to Covid-19
5.4 Teva
5.4.1 Teva Profile
5.4.2 Teva Main Business and Company’s Total Revenue
5.4.3 Teva Products, Services and Solutions
5.4.4 Teva Revenue (US$ Million) (2015-2020)
5.4.5 Teva Recent Development and Reaction to Covid-19
5.5 Takeda
5.5.1 Takeda Profile
5.5.2 Takeda Main Business and Company’s Total Revenue
5.5.3 Takeda Products, Services and Solutions
5.5.4 Takeda Revenue (US$ Million) (2015-2020)
5.5.5 Takeda Recent Development and Reaction to Covid-19
5.6 Samyang Biopharmaceuticals
5.6.1 Samyang Biopharmaceuticals Profile
5.6.2 Samyang Biopharmaceuticals Main Business and Company’s Total Revenue
5.6.3 Samyang Biopharmaceuticals Products, Services and Solutions
5.6.4 Samyang Biopharmaceuticals Revenue (US$ Million) (2015-2020)
5.6.5 Samyang Biopharmaceuticals Recent Development and Reaction to Covid-19
5.7 Tolmar
5.7.1 Tolmar Profile
5.7.2 Tolmar Main Business and Company’s Total Revenue
5.7.3 Tolmar Products, Services and Solutions
5.7.4 Tolmar Revenue (US$ Million) (2015-2020)
5.7.5 Tolmar Recent Development and Reaction to Covid-19
5.8 AstraZeneca
5.8.1 AstraZeneca Profile
5.8.2 AstraZeneca Main Business and Company’s Total Revenue
5.8.3 AstraZeneca Products, Services and Solutions
5.8.4 AstraZeneca Revenue (US$ Million) (2015-2020)
5.8.5 AstraZeneca Recent Development and Reaction to Covid-19
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business and Company’s Total Revenue
5.9.3 Novartis Products, Services and Solutions
5.9.4 Novartis Revenue (US$ Million) (2015-2020)
5.9.5 Novartis Recent Development and Reaction to Covid-19
5.10 Aspen
5.10.1 Aspen Profile
5.10.2 Aspen Main Business and Company’s Total Revenue
5.10.3 Aspen Products, Services and Solutions
5.10.4 Aspen Revenue (US$ Million) (2015-2020)
5.10.5 Aspen Recent Development and Reaction to Covid-19
6 North America Cancer Hormone Therapy Drugs by Players and by Application
6.1 North America Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
6.2 North America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
7 Europe Cancer Hormone Therapy Drugs by Players and by Application
7.1 Europe Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
7.2 Europe Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
8 China Cancer Hormone Therapy Drugs by Players and by Application
8.1 China Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
8.2 China Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
9 Rest of Asia Pacific Cancer Hormone Therapy Drugs by Players and by Application
9.1 Rest of Asia Pacific Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
10 Latin America Cancer Hormone Therapy Drugs by Players and by Application
10.1 Latin America Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
10.2 Latin America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
11 Middle East & Africa Cancer Hormone Therapy Drugs by Players and by Application
11.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
12 Cancer Hormone Therapy Drugs Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
